GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Bioethics Ltd (OTCPK:BOTH) » Definitions » EV-to-EBITDA

Bioethics (Bioethics) EV-to-EBITDA

: -12.98 (As of Today)
View and export this data going back to . Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bioethics's enterprise value is $0.66 Mil. Bioethics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.05 Mil. Therefore, Bioethics's EV-to-EBITDA for today is -12.98.

The historical rank and industry rank for Bioethics's EV-to-EBITDA or its related term are showing as below:

BOTH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -114.89   Med: 0   Max: 0
Current: -12.98

BOTH's EV-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 9.07 vs BOTH: -12.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-18), Bioethics's stock price is $0.2101. Bioethics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.090. Therefore, Bioethics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bioethics EV-to-EBITDA Historical Data

The historical data trend for Bioethics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioethics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -114.21 -22.26 -43.23 -15.24 -13.63

Bioethics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.24 -13.80 -14.60 -14.68 -13.63

Competitive Comparison

For the Shell Companies subindustry, Bioethics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioethics EV-to-EBITDA Distribution

For the Diversified Financial Services industry and Financial Services sector, Bioethics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bioethics's EV-to-EBITDA falls into.



Bioethics EV-to-EBITDA Calculation

Bioethics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.662/-0.051
=-12.98

Bioethics's current Enterprise Value is $0.66 Mil.
Bioethics's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioethics  (OTCPK:BOTH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bioethics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.2101/-0.090
=At Loss

Bioethics's share price for today is $0.2101.
Bioethics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bioethics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bioethics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioethics (Bioethics) Business Description

Traded in Other Exchanges
N/A
Address
1661 Lakeview Circle, Ogden, UT, USA, 84403
Bioethics Ltd is a shell company.

Bioethics (Bioethics) Headlines

No Headlines